Open an account

Accuray

ARAY · NASDAQ

$0.142−$0.001 (−0.70%)TodayMarket closed ·
Prev close $0.143

About ARAY

Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.

Employees
990
Headquarters
Madison, Wisconsin
Listed
Feb 8, 2007
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
accuray.com

ARAY key statistics

Market cap
16.98M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
2.54M
Volume
1.93M
Open price
$0.1466
High today
$0.1529
Low today
$0.142
52 Week high
$1.79
52 Week low
$0.1352

Accuray (ARAY) at a glance

Accuray (ARAY) last traded at $0.142, with a market cap of 16.98M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.142 and $0.1529. The current price is 0.0% above the day's low and 7.1% below its high.

Volume so far is 1.93M shares, below the average of 2.54M shares a day.

Over the past year Accuray has ranged from $0.1352 to $1.79, and now sits 0% of the way up that range.

Accuray met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q4 FY26 it reported $0.004 per share against an estimate of -$0.102.

The average analyst price target is $0.357, 151.4% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 2 analyst ratings say Buy
  • Buy0.0%
  • Hold100.0%
  • Sell0.0%
Price target · 3 analystsAvg $0.357
Low
$0.3535
Now
$0.142
High
$0.3675

ARAY earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 78.0% on average.

  1. Q1 FY25: reported -$0.04 per share against an estimate of -$0.0536
  2. Q2 FY25: reported $0.02 per share against an estimate of -$0.0255
  3. Q3 FY25: reported -$0.01 per share against an estimate of -$0.051
  4. Q4 FY25: reported $0.001 per share against an estimate of $0.0179
  5. Q1 FY26: reported -$0.14 per share against an estimate of -$0.0612
  6. Q2 FY26: reported -$0.11 per share against an estimate of -$0.1122
  7. Q3 FY26: reported -$0.09 per share against an estimate of -$0.0459
  8. Q4 FY26: reported $0.004 per share against an estimate of -$0.102

ARAY news

  • Press releasePRNewswire

    Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director

  • Neeraj Jain

    Why Is Accuray Stock Gaining Monday?

  • Avi Kapoor

    Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

  • Press releasePRNewswire

    Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform

  • Press releasePRNewswire

    Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities

  • Press releasePRNewswire

    Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results

  • Press releasePRNewswire

    Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

Similar companies

Companies in the same industry as Accuray

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.